Literature DB >> 22697426

Fast-degradable microbeads encapsulating human umbilical cord stem cells in alginate for muscle tissue engineering.

Jun Liu1, Hongzhi Zhou, Michael D Weir, Hockin H K Xu, Qianming Chen, Carroll Ann Trotman.   

Abstract

Human umbilical cord mesenchymal stem cells (hUCMSCs) are inexhaustible and can be obtained without an invasive surgery. To date, there has been no report on seeding hUCMSCs in three-dimensional scaffolds for muscle tissue engineering. The objectives of this study were to (1) investigate hUCMSC seeding in a scaffold for muscle engineering and (2) develop a novel construct consisting of hUCMSC-encapsulating and fast-degradable microbeads inside a hydrogel matrix. The rationale was that the hydrogel matrix would maintain the defect volume, while the microbeads would degrade to release the cells and concomitantly create macropores in the matrix. hUCMSCs were encapsulated in alginate-fibrin microbeads, which were packed in an Arg-Gly-Asp (RGD)-modified alginate matrix (AM). This construct is referred to as hUCMSC-microbead-AM. The control consisted of the usual cell encapsulation in AM without microbeads (referred to as hUCMSC-AM). In the hUCMSC-AM construct, the hUCMSCs showed as round dots with no spreading at 1-14 days. In contrast, cells in the hUCMSC-microbead-AM construct had a healthy spreading and elongated morphology. The microbeads successfully degraded and released the cells at 8 days. Myogenic expressions for hUCMSC-microbead-AM were more than threefold those of hUCMSC-AM (p<0.05). Immunofluorescence for myogenic markers was much stronger for hUCMSC-microbead-AM than hUCMSC-AM. Muscle creatine kinase of hUCMSC-microbead-AM at 14 days was twofold that of hUCMSC-AM (p<0.05). In conclusion, hUCMSC encapsulation in novel fast-degradable microbeads inside a hydrogel matrix was investigated for muscle engineering. Compared to the usual method of seeding cells in a hydrogel matrix, hUCMSC-microbead-AM construct had greatly improved cell viability and myogenic differentiation, and hence, is promising to enhance muscle regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22697426      PMCID: PMC3482877          DOI: 10.1089/ten.TEA.2011.0658

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  67 in total

1.  Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing.

Authors:  Raphael Gorodetsky; Akiva Vexler; Lilia Levdansky; Gerard Marx
Journal:  Methods Mol Biol       Date:  2004

2.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

3.  The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering.

Authors:  Hongzhi Zhou; Hockin H K Xu
Journal:  Biomaterials       Date:  2011-07-14       Impact factor: 12.479

Review 4.  Materials in particulate form for tissue engineering. 2. Applications in bone.

Authors:  G A Silva; O P Coutinho; P Ducheyne; R L Reis
Journal:  J Tissue Eng Regen Med       Date:  2007 Mar-Apr       Impact factor: 3.963

Review 5.  Niche regulation of muscle satellite cell self-renewal and differentiation.

Authors:  Shihuan Kuang; Mark A Gillespie; Michael A Rudnicki
Journal:  Cell Stem Cell       Date:  2008-01-10       Impact factor: 24.633

6.  Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.

Authors:  Jos L J van der Velden; Ramon C J Langen; Marco C J M Kelders; Emiel F M Wouters; Yvonne M W Janssen-Heininger; Annemie M W J Schols
Journal:  Am J Physiol Cell Physiol       Date:  2005-09-14       Impact factor: 4.249

7.  Alginate type and RGD density control myoblast phenotype.

Authors:  Jon A Rowley; David J Mooney
Journal:  J Biomed Mater Res       Date:  2002-05

8.  5-Azacytidine induces cardiac differentiation of human umbilical cord-derived mesenchymal stem cells by activating extracellular regulated kinase.

Authors:  Qian Qian; Hui Qian; Xu Zhang; Wei Zhu; Yongmin Yan; Shengqin Ye; Xiujuan Peng; Wei Li; Zhe Xu; Lingyun Sun; Wenrong Xu
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

9.  Heat denaturation of fibrinogen to develop a biomedical matrix.

Authors:  Gerard Marx; Xiaode Mou; Anna Hotovely-Salomon; Lilia Levdansky; Elena Gaberman; Dimitry Belenky; Raphael Gorodetsky
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-01       Impact factor: 3.368

10.  Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate.

Authors:  Nathaniel Huebsch; Praveen R Arany; Angelo S Mao; Dmitry Shvartsman; Omar A Ali; Sidi A Bencherif; José Rivera-Feliciano; David J Mooney
Journal:  Nat Mater       Date:  2010-04-25       Impact factor: 43.841

View more
  15 in total

1.  Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells.

Authors:  Limin Wang; Mark L Weiss; Michael S Detamore
Journal:  Recent Pat Regen Med       Date:  2013

Review 2.  Sources, Characteristics, and Therapeutic Applications of Mesenchymal Cells in Tissue Engineering.

Authors:  Rosa Angelica Gonzalez-Vilchis; Angelica Piedra-Ramirez; Carlos Cesar Patiño-Morales; Concepcion Sanchez-Gomez; Nohra E Beltran-Vargas
Journal:  Tissue Eng Regen Med       Date:  2022-01-29       Impact factor: 4.169

3.  Materials-Directed Differentiation of Mesenchymal Stem Cells for Tissue Engineering and Regeneration.

Authors:  J Kent Leach; Jacklyn Whitehead
Journal:  ACS Biomater Sci Eng       Date:  2017-03-14

4.  3D brown adipogenesis to create "Brown-Fat-in-Microstrands".

Authors:  Andrea M Unser; Bridget Mooney; David T Corr; Yu-Hua Tseng; Yubing Xie
Journal:  Biomaterials       Date:  2015-10-08       Impact factor: 12.479

5.  Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering.

Authors:  Jun Liu; Hockin H K Xu; Hongzhi Zhou; Michael D Weir; Qianming Chen; Carroll Ann Trotman
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

6.  Reprogramming of mesenchymal stem cells derived from iPSCs seeded on biofunctionalized calcium phosphate scaffold for bone engineering.

Authors:  Jun Liu; Wenchuan Chen; Zhihe Zhao; Hockin H K Xu
Journal:  Biomaterials       Date:  2013-07-24       Impact factor: 12.479

Review 7.  Opportunities and challenges in three-dimensional brown adipogenesis of stem cells.

Authors:  Andrea M Unser; Yangzi Tian; Yubing Xie
Journal:  Biotechnol Adv       Date:  2015-07-29       Impact factor: 14.227

8.  Osteogenic differentiation of human mesenchymal stem cells through alginate-graft-poly(ethylene glycol) microsphere-mediated intracellular growth factor delivery.

Authors:  Tianxin Miao; Krithika S Rao; Jeffrey L Spees; Rachael A Oldinski
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

9.  Effect of NELL1 gene overexpression in iPSC-MSCs seeded on calcium phosphate cement.

Authors:  Jun Liu; Wenchuan Chen; Zhihe Zhao; Hockin H K Xu
Journal:  Acta Biomater       Date:  2014-08-23       Impact factor: 8.947

Review 10.  Alginate Microencapsulation for Three-Dimensional In Vitro Cell Culture.

Authors:  Sung-Min Kang; Ji-Hoon Lee; Yun Suk Huh; Shuichi Takayama
Journal:  ACS Biomater Sci Eng       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.